CRMD compared with ALGS: revenue, margins and what each company keeps, and the suppliers and customers both name

CRMDCorMedix Inc.

Mkt capRevenueRevenue

ALGSAligos Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CRMDCorMedix Inc.

ALGSAligos Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ALGS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CRMD 0

None

Shared 0

No disclosed counterparties: CRMD.

Only ALGS 15

MRKMerck Sharp & Dohmecustomer

ADCTADC Therapeutics (ADCT)customer

—Emory Universityunlistedsupplier

—Rega Institute at Katholieke Universiteit Leuven (KU Leuven)unlistedsupplier

11 more · ALGS chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

CRMD, solidALGS, dashed

CRMDCorMedix Inc.

5.69▼−25.51%· post 5.69

Mkt cap$526.7MRevenue$102MQ2 FY26Revenue$298MFY25

ALGSAligos Therapeutics, Inc.

4.84▼−3.78%· post 5.14

ClosedOct 30 '26

Mkt cap$59.9MRevenue$28MQ2 FY26Revenue$2MFY25

Compare

ClosedOct 30 '26

CRMDCorMedix Inc.

ALGSAligos Therapeutics, Inc.

5.69▼−25.51%post 5.69

Price

4.84▼−3.78%post 5.14

$526.7M

Mkt cap

$59.9M

Q2 FY26$102M

Revenue

$28MQ2 FY26

FY25$298M

Revenue

$2MFY25

CRMD5.69▼−25.51%vsALGS4.84▼−3.78%ClosedOct 30 '26